Today: 27 April 2026
Browse Category

Stock Market 20 December 2025

Berkshire Hathaway Stock (BRK.B) in Focus on Dec. 20, 2025: Buffett’s CEO Handover, Record Cash, Portfolio Shifts, and the 2026 Outlook

Berkshire Hathaway Stock (BRK.B) in Focus on Dec. 20, 2025: Buffett’s CEO Handover, Record Cash, Portfolio Shifts, and the 2026 Outlook

Berkshire Hathaway confirmed Greg Abel will become CEO on Jan. 1, 2026, ending Warren Buffett’s six-decade tenure. Berkshire’s Class B shares closed at $494.53 on Dec. 19, down 1.76%. The company announced a major leadership reshuffle in December, including new roles for Adam Johnson, Nancy Pierce, and Charles Chang. Todd Combs will depart for JPMorgan Chase.
20 December 2025
··
HYMC Stock News and Forecast: Hycroft Mining’s Silver Drill Results, Insider Buying, and 2026 Catalysts as of Dec. 20, 2025

HYMC Stock News and Forecast: Hycroft Mining’s Silver Drill Results, Insider Buying, and 2026 Catalysts as of Dec. 20, 2025

Hycroft Mining shares traded around $16.42 on Dec. 20 after a volatile session, with volume near 4.8 million shares. The stock surged following a Dec. 15 update reporting the highest silver grades yet at its Nevada Vortex target, including a 30.8-meter intercept at 438.58 g/t silver. Drilling continues at both Vortex and Brimstone.
20 December 2025
···
Firefly Aerospace Stock (NASDAQ: FLY) News, Forecasts, and Analysis for Dec. 20, 2025

Firefly Aerospace Stock (NASDAQ: FLY) News, Forecasts, and Analysis for Dec. 20, 2025

Firefly Aerospace shares surged 22.82% Friday to $24.65, with after-hours trading near $25.44. The move followed new analyst coverage from KeyBanc and the appointment of Ramon Sanchez as COO, focused on scaling production. The stock has traded between $16 and $73.80 over the past year. Investors remain focused on execution risks and upcoming lunar-mission partnerships.
20 December 2025
···
Carnival Corporation & plc Stock (CCL) Surges on Dividend Return, Record 2025 Results, and 2026 Forecasts — What Investors Are Watching

Carnival Corporation & plc Stock (CCL) Surges on Dividend Return, Record 2025 Results, and 2026 Forecasts — What Investors Are Watching

Carnival shares jumped as much as 10.2% after reporting a fourth-quarter adjusted profit of $0.34 per share, beating expectations, and announcing the return of quarterly dividends. The company posted record 2025 results, including $2.8 billion net income and $26.6 billion revenue. Carnival last paid a dividend in early 2020 before suspending payouts during the pandemic.
20 December 2025
·····
Axon Enterprise (AXON) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of December 20, 2025

Axon Enterprise (AXON) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of December 20, 2025

Axon Enterprise shares closed at $594.20 on Dec. 19, up 5.4% after announcing early redemption of its 0.50% convertible notes due 2027. The company notified holders they may convert notes until Feb. 6, 2026, with settlement set for Feb. 10. Recent headlines also include new municipal AI-policing contracts and an analyst price-target cut that kept a bullish rating.
20 December 2025
·
BigBear.ai Stock News (BBAI) on Dec. 20, 2025: Border-Security Partnership Sparks Rally as Dilution Vote Looms

BigBear.ai Stock News (BBAI) on Dec. 20, 2025: Border-Security Partnership Sparks Rally as Dilution Vote Looms

BigBear.ai shares jumped 11% Friday to $6.26 after announcing a partnership with C Speed to integrate AI with radar systems for defense and homeland security. Trading volume hit 218 million shares. The company also faces an upcoming shareholder vote that could affect its capital strategy and potential dilution risk. No financial terms were disclosed for the C Speed deal.
20 December 2025
··
Ciena Stock (CIEN) News, Forecasts and Analyst Targets as of Dec. 20, 2025: AI Networking Tailwinds Meet a Stretched Valuation Debate

Ciena Stock (CIEN) News, Forecasts and Analyst Targets as of Dec. 20, 2025: AI Networking Tailwinds Meet a Stretched Valuation Debate

Ciena shares closed at $230.34 on Dec. 19, up 9.32% after reporting fiscal Q4 revenue of $1.352 billion, a 20% jump year over year. The company issued 2026 guidance above expectations, projecting up to $6.1 billion in revenue. Analysts raised price targets, while some questioned valuation. Ciena cited AI and cloud demand as key drivers and reported a record order backlog entering 2026.
20 December 2025
··
Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston shares fell about 20% on December 19 after the company reported fiscal Q2 2026 results that beat expectations but maintained a cautious full-year outlook. The stock closed near $43.94 on December 20. Despite 8% volume growth, price/mix dropped 8%, pressuring margins. Investors focused on the company’s reliance on discounting and muted demand signals.
20 December 2025
···
Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group shares surged 14.6% to $89.46 Friday, Dec. 19, on heavy trading after launching its AI Cloud 3.1 platform with NVIDIA Blackwell Ultra compute. The Amsterdam-based company, formerly Yandex, has become a key AI infrastructure stock, competing with Amazon and Google. Investors remain focused on Nebius’s rapid expansion and spending to meet AI demand.
20 December 2025
··
Virgin Galactic (SPCE) Stock News and Forecast — Dec. 20, 2025: Debt “Reset,” Analyst Targets, and the Long Road to Delta Flights

Virgin Galactic (SPCE) Stock News and Forecast — Dec. 20, 2025: Debt “Reset,” Analyst Targets, and the Long Road to Delta Flights

Virgin Galactic shares rose 6.71% to $3.50 on Friday, capping a four-day rally after the company repurchased $354.6 million of its 2027 convertible notes and issued new debt and equity. Trading volume hit 7.9 million, well above average. The stock remains 48% below its 52-week high. Virgin Galactic also announced a high-altitude imaging deal with Lawrence Livermore National Laboratory.
20 December 2025
··
Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab shares closed at a record $70.52 Friday, up 17.7%, after announcing its largest contract to date: an $805 million U.S. Space Force award to build 18 missile-tracking satellites. The deal is part of a $3.5 billion Space Development Agency program with launches targeted by 2029.
20 December 2025
····
Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

Luminar Technologies stock closed at $0.6044 on December 19, 2025, amid heavy trading after the company filed for Chapter 11 bankruptcy on December 15. Nasdaq delisting is imminent. Luminar warned that stock prices during bankruptcy may not reflect eventual shareholder outcomes. Over 90% of first-lien and 85% of second-lien noteholders back the restructuring plan.
20 December 2025
·
National Grid plc Stock (NG.L): Share Price, RIIO‑T3 Decision, Sea Link Contracts and Analyst Forecasts as of 20 December 2025

National Grid plc Stock (NG.L): Share Price, RIIO‑T3 Decision, Sea Link Contracts and Analyst Forecasts as of 20 December 2025

National Grid shares closed at 1,142p on 19 December 2025, up nearly 24% over the past year, with a dividend yield near 4.1%. Investors are watching Ofgem’s RIIO-T3 final determination, which sets a 6.12% allowed cost of equity from April 2026. National Grid expects to respond to licence terms in early March 2026. The company’s market cap stands at about £56.6 billion.
20 December 2025
·
Rio Tinto (RIO.L, NYSE: RIO) Stock: Latest News, Forecasts, and Analyst Outlook as of Dec. 20, 2025

Rio Tinto (RIO.L, NYSE: RIO) Stock: Latest News, Forecasts, and Analyst Outlook as of Dec. 20, 2025

Rio Tinto shares closed Friday at 5,838p in London, up 4.46% for the week, and $78.33 in New York. The company’s new CEO, Simon Trott, unveiled a strategy overhaul with upgraded copper and bauxite guidance, lower copper unit costs, and plans for asset sales or partnerships. Analysts noted a push for productivity gains, cost cuts, and up to $10 billion in divestments.
20 December 2025
···
Standard Chartered PLC Stock (LSE: STAN) Near 52-Week High on Buybacks and Upgrades—But Regulators and Fraud Probe Add New Risk

Standard Chartered PLC Stock (LSE: STAN) Near 52-Week High on Buybacks and Upgrades—But Regulators and Fraud Probe Add New Risk

Standard Chartered shares closed at 1,788.50p on December 20, near a 52-week high and up roughly 80%–90% year-to-date. The bank disclosed buying 535,961 shares on December 18 as part of a buyback program, with nearly US$984 million spent so far. German regulators have ordered action at the bank’s local unit, and Indian authorities are probing alleged client fund diversion.
20 December 2025
·
GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK agreed to a U.S. drug-pricing deal covering its respiratory portfolio, securing a three-year exemption from tariffs and pledging lower Medicaid prices and direct-to-consumer discounts. The company also received fresh FDA approval for a severe asthma drug and expanded vaccine indications in Europe. GSK’s ADR closed Friday, Dec. 19, at $48.61.
20 December 2025
···
1 … 891 892 893 894 895 … 1,394

Stock Market Today

  • Wall Street's Fear Gauge VIX Rises Amid S&P 500 Rally, Signal Mixed Market Sentiment
    April 27, 2026, 5:39 PM EDT. The Cboe Volatility Index (VIX), Wall Street's key "fear gauge," has unexpectedly risen alongside the S&P 500 hitting record highs. Typically, the VIX moves inversely to stocks, but this concurrent surge points to mixed investor sentiment. Some traders suspect hedging against geopolitical risks like the Iran war and rising crude oil prices, signaling potential near-term volatility. Alternatively, robust buying of call options, especially in semiconductor and tech stocks leading the rally, inflates options premiums and keeps the VIX elevated. Notably, semiconductor ETF VanEck Semiconductor (SMH) shows 25% higher call premiums than puts. A large bullish bet in Marvell Technology highlights investor appetite for further gains despite recent doubling since earnings. This unusual price dynamic suggests heightened caution amid optimism in the market.

Latest article

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

27 April 2026
Astronomers using ALMA have measured deuterated water in interstellar comet 3I/ATLAS, finding a deuterium-to-hydrogen ratio over 40 times higher than Earth’s oceans. The result indicates the comet formed in a much colder environment than the early solar system. The data were collected just after the comet’s perihelion as it now leaves the solar system.
Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Go toTop